No link to cardiac valvulopathy was seen in cabergoline treated patients

<p><strong>Objective:</strong> To evaluate the association between use of cabergoline in patients with prolactinoma and risk of developing clinically relevant cardiac valvular disease.</p> <p><strong>Method:</strong> This was a descriptive cross sectional st...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: K Dharshini, Noel Somasundaram, HMDPK Senevirathna, S Raj Kumar
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: Sri Lanka College of Endocrinologists 2012-10-01
Цуврал:Sri Lanka Journal of Diabetes Endocrinology and Metabolism
Нөхцлүүд:
Онлайн хандалт:https://sjdem.sljol.info/articles/4775